Olympus-backed MaxQ Medical raises $31.5m for prostate care platform’s advancement

MaxQ Medical, backed by Olympus, raised $31.5 million to advance its integrated prostate care platform that combines imaging with tissue-selective therapy in a single transurethral procedure. The funding supports continued development and commercialization of the technology, which addresses minimally invasive treatment of benign prostatic hyperplasia and related conditions.